Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-02-01 Sale |
2024-02-02 9:26 pm |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
12,477 | $3.8394 | $47,904 | 207,623 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-31 Option Award |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
128,100 | $0 | 211,561 (Direct) |
View |
2025-01-31 Exercise |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
33,333 | $0 | 211,561 (Direct) |
View |
2025-01-31 Tax Withholding |
2025-02-04 6:00 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
12,062 | $3.06 | 211,561 (Direct) |
View |
2024-01-31 Option Award |
2024-02-02 9:26 pm |
N/A 2034-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
120,100 | $0 | 207,623 (Direct) |
View |
2024-01-31 Exercise |
2024-02-02 9:26 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
33,334 | $0 | 207,623 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 6:38 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
240,000 | $0 | 240,000 (Direct) |
View |
2022-01-31 Option Award |
2022-02-02 5:15 pm |
N/A 2032-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
120,000 | $0 | 120,000 (Direct) |
View |
2021-01-29 Option Award |
2021-02-01 4:50 pm |
N/A 2031-01-28 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks |
71,750 | $0 | 71,750 (Direct) |
View |
2020-10-29 Option Award |
2020-10-30 5:40 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2020-10-29 8:50 pm |
N/A 2029-12-12 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks |
0 | $0 | 359,732 (Direct) |
View |